Vericel on Track for Over 30% MACI Growth in 2021
Armed with expanded coverage from UnitedHealthcare, Vericel expects to growth MACI in the low- to mid- +30% range in 2021....
Armed with expanded coverage from UnitedHealthcare, Vericel expects to growth MACI in the low- to mid- +30% range in 2021....
Record Mazor robot sales, combined with near-record imaging and navigation sales, helped MDT offset COVID-related core spine declines....
The company's orthopedics business declined -13.1% in 2020. Integra closed the divesture of its ortho business to SNN in early...
Despite pandemic-related surgical restrictions in its key markets, Amplitude's foot & ankle business grew 30% in FY 2Q21....
The company started 4Q20 with momentum, but COVID restrictions from mid-October derailed efforts in the U.S. and large European markets....
Armed with its newly assembled dedicated foot and ankle business, DJO expects double-digit growth in 2021 compared to 2019....
The company set records for total sales and enabling technology in 4Q20, pushing Globus to an all-time high revenue mark...
Despite performing better than many peers in 4Q20 (-1.5%), the company expects more pandemic-related declines in the first quarter of...
Despite some volume increases in Japan and the U.S., the company continued to slide due to COVID and erosion of...
The company's sports medicine business declined -19.1% in 2020 and faces difficult recovery prospects without organized sports activity....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.